Arming adoptively transferred T-cells with drug-loaded nanoparticles for cancer immunotherapy
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, February 2016. === Cataloged from PDF version of thesis. "November 2015." === Includes bibliographical references (pages 95-103). === In adoptive cell therapy (ACT), autologous tumor-specific T-cel...
Main Author: | Zheng, Yiran, Ph. D. Massachusetts Institute of Technology |
---|---|
Other Authors: | Darrell J. Irvine. |
Format: | Others |
Language: | English |
Published: |
Massachusetts Institute of Technology
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/103697 |
Similar Items
-
Engineering more potent vaccines for the treatment of cancer and autoimmunity
by: Mehta, Naveen K.,Ph.D.Massachusetts Institute of Technology.
Published: (2019) -
High throughput microfluidic technologies for cell separation and single-cell analysis
by: Wu, Lidan, Ph. D. Massachusetts Institute of Technology
Published: (2016) -
Tumor microenvironmental control of metastasis : effects of the immune cells and physical forces on cell migration
by: Li, Ran, Ph. D. Massachusetts Institute of Technology
Published: (2017) -
pH-sensitive core-shell nanoparticles for intracellular drug delivery
by: Hu, Yuhua, Ph. D. Massachusetts Institute of Technology
Published: (2008) -
Systematic analysis of the role of differential expression of microRNAs associated with cell death decisions
by: Guillén, Nancy, Ph. D. Massachusetts Institute of Technology
Published: (2014)